Skip to content

India’s MedTech Momentum: A Gateway to Asia’s Growth 

By Ms. Wara Samar

India’s medical devices sector is emerging as a pivotal force in the global healthcare landscape, offering a blend of scale, innovation, and opportunity. Estimated at USD 15.35 billion in 2023 and projected to grow to USD 20.51 billion by 2029, the market is expanding steadily with a compound annual growth rate (CAGR) of 5.35%. This … Continued

Mittal Consulting Helps Startups Think Big—and Navigate FDA Fast

By Ms. Wara Samar

At the heart of every transformative medical technology lies a team navigating the complex journey from concept to clinic. For early-stage medtech startups, this path can be especially daunting—marked by stringent regulations, limited resources, and the constant pressure to get life-saving innovations to patients faster. That’s where Mittal Consulting steps in.  Founded by Kristen Mittal … Continued

How Zapyrus Intelligence Helps MedTech Service Providers Win in a Volatile Market 

By Ms. Wara Samar

According to the Zapyrus 2025 Q1 financial data, the MedTech sector secured an impressive $18 billion in funding during the first quarter alone, marking a 47% increase over Q1 2024. However, this financial upswing doesn’t automatically translate into predictable growth for every MedTech stakeholder. For service providers like contract research organizations (CROs), regulatory consultants, manufacturers, … Continued

Freespira Wins FDA Clearance to Treat Adolescents with Anxiety and PTSD at Home 

By Ms. Wara Samar

Freespira, the developer of the first FDA-cleared at-home treatment for panic disorder (PD) and post-traumatic stress disorder (PTSD), has announced a major expansion of its therapeutic reach. With FDA 510(k) clearance (K233337), Freespira is now indicated for use in adolescents aged 13 to 17, marking a milestone in digital mental health solutions for younger populations.  … Continued

Sheba Medical Center-Backed Mentaily Secures $3M to Scale AI-Powered Mental Health Platform  

By Ms. Wara Samar

Mentaily, the developer of AI-powered tools for the assessment, triage, and diagnosis of mental disorders, has announced the closing of a $3 million seed funding round. The round was led by US- and Israeli-based family offices, with participation from impact investors The Rashi Foundation and Sheatufim, as well as several prominent angel investors in digital … Continued

Glucotrack Receives Green Light for Long-Term Study of Implantable Blood Glucose Monitor 

By Ms. Wara Samar

Glucotrack, a medical device company advancing diabetes care through novel technologies, has announced that it has received ethical approval from the Human Research Ethics Committee (HREC) of St. Vincent’s Hospital Melbourne to conduct a long-term clinical study of its implantable continuous blood glucose monitor (CBGM). The approval marks a key step in the company’s path … Continued

Meridian Health Ventures Launches €44.7M Transatlantic Fund to Bridge UK and US HealthTech Growth 

By Ms. Wara Samar

Meridian Health Ventures – previously KHP Ventures – has announced the launch of a new transatlantic venture capital fund, securing Limited Partner commitments totalling approximately €44.7 million. This milestone fund is designed to back HealthTech superscalers with strong potential to grow both within the UK’s NHS and across the US healthcare market.  Founded in 2021, … Continued

MedTech World and Malta Union of Midwives and Nurses Forge Strategic Partnership Ahead of MedTech Malta 2025 

By Ms. Wara Samar

MedTech World is pleased to announce a strategic partnership with the Malta Union of Midwives and Nurses (MUMN) in the lead-up to MedTech Malta 2025, the international flagship event returning to the Mediterranean Conference Centre in Valletta between 12–14 November 2025. This partnership marks an important step in integrating clinical voices directly into the broader … Continued

illumicell AI Secures $2M to Deliver Lab-Grade Fluid Diagnostics in Minutes at the Point-of-Care – starting with Male Fertility

By Ms. Wara Samar

In a significant step forward for male fertility care and point-of-care diagnostics, illumicell AI, a Swiss-American techmed startup, has successfully closed a $2M pre-seed funding round. This capital injection will accelerate the launch of its groundbreaking real-time AI platform for cellular diagnostics — starting with the fertility space. Founded by Harvard-trained physician Dr. Michel Bielecki, … Continued